When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DARE - Dare Bioscience gives back most of its strong gains from Tuesday's FDA approval
Dare Bioscience Inc.
Daré Bioscience (DARE +5.8%), which saw it shares soar ~30% on Tuesday following FDA approval of Xaciato (clindamycin gel) for bacterial vaginosis, has seen a chunk of those gains evaporate since then. While shares are up again today, since Monday's close through this afternoon, shares are only up ~5% overall. Check out Daré's Q3 2021 earnings.